Erratum to: Oral intake of a combination of glucosyl hesperidin and caffeine elicits an antiobesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial (Q42352156)
Jump to navigation
Jump to search
scientific article published on 12 May 2017
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Erratum to: Oral intake of a combination of glucosyl hesperidin and caffeine elicits an antiobesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial |
scientific article published on 12 May 2017 |
Statements
1 reference
Erratum to: Oral intake of a combination of glucosyl hesperidin and caffeine elicits an antiobesity effect in healthy, moderately obese subjects: a randomized double-blind placebo-controlled trial (English)
1 reference
Tatsuya Ohara
1 reference
Koutarou Muroyama
1 reference
Yoshihiro Yamamoto
1 reference
Shinji Murosaki
1 reference
12 May 2017
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference